These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17591142)

  • 21. Recombinant human activated protein C in severe sepsis.
    Mann HJ
    Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S19-23. PubMed ID: 11885409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drotrecogin alfa (activated) in severe sepsis.
    Friedrich JO
    N Engl J Med; 2006 Jan; 354(1):94-6; author reply 94-6. PubMed ID: 16394311
    [No Abstract]   [Full Text] [Related]  

  • 23. Why do patients who have acute lung injury/acute respiratory distress syndrome die from multiple organ dysfunction syndrome? Implications for management.
    Vincent JL; Zambon M
    Clin Chest Med; 2006 Dec; 27(4):725-31; abstract x-xi. PubMed ID: 17085258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drotrecogin alfa (activated): is there room for improvement?
    Cunningham K; Jankovic Z
    Eur J Anaesthesiol; 2008 Nov; 25(11):952. PubMed ID: 18533075
    [No Abstract]   [Full Text] [Related]  

  • 25. [Exchange transfusion in cases of falciparum malaria].
    Owen-Falkenberg A; Wisborg T; Bjorvatn B
    Nord Med; 1991; 106(10):270-1. PubMed ID: 1945797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective ambulatory management of imported falciparum malaria: a 5-year prospective study.
    Bottieau E; Clerinx J; Colebunders R; Van den Enden E; Wouters R; Demey H; Van Esbroeck M; Vervoort T; Van Gompel A; Van den Ende J
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):181-8. PubMed ID: 17297605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe falciparum malaria: an important cause of multiple organ failure in Indian intensive care unit patients.
    Krishnan A; Karnad DR
    Crit Care Med; 2003 Sep; 31(9):2278-84. PubMed ID: 14501957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure.
    Albuali WH; Singh RN; Fraser DD; Scott LA; Kornecki A
    Saudi Med J; 2005 Aug; 26(8):1289-92. PubMed ID: 16127532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.
    Vincent JL; Angus DC; Artigas A; Kalil A; Basson BR; Jamal HH; Johnson G; Bernard GR;
    Crit Care Med; 2003 Mar; 31(3):834-40. PubMed ID: 12626993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis.
    Grinnell BW; Joyce D
    Crit Care Med; 2001 Jul; 29(7 Suppl):S53-60; discussion S60-1. PubMed ID: 11445735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations on the use of adjunct red blood cell exchange transfusion in the treatment of severe Plasmodium falciparum malaria.
    Shelat SG; Lott JP; Braga MS
    Transfusion; 2010 Apr; 50(4):875-80. PubMed ID: 20003050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum and Mycoplasma pneumoniae co-infection presenting with cerebral malaria manifesting orofacial dyskinesia and haemophagocytic lymphohistiocytosis.
    Weeratunga P; Rathnayake G; Sivashangar A; Karunanayake P; Gnanathasan A; Chang T
    Malar J; 2016 Sep; 15(1):461. PubMed ID: 27609213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmalaria neurological syndrome after treatment of Plasmodium falciparum malaria in the United States.
    Falchook GS; Malone CM; Upton S; Shandera WX
    Clin Infect Dis; 2003 Jul; 37(2):e22-4. PubMed ID: 12856230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation dysfunction in sepsis and multiple organ system failure.
    Nimah M; Brilli RJ
    Crit Care Clin; 2003 Jul; 19(3):441-58. PubMed ID: 12848314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Severe sepsis treated with activated protein C].
    Frøyshov S; Jacobsen D; Bjertnaes L; Flaatten H
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):779-81. PubMed ID: 15039807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
    Davies A; Ridley S; Hutton J; Chinn C; Barber B; Angus DC
    Anaesthesia; 2005 Feb; 60(2):155-62. PubMed ID: 15644013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of severe malaria in the intensive care unit.
    Cheng MP; Yansouni CP
    Crit Care Clin; 2013 Oct; 29(4):865-85. PubMed ID: 24094382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, observational study of Xigris Use in the United States (XEUS).
    Steingrub JS; Cheatham ML; Woodward B; Wang HT; Effron MB;
    J Crit Care; 2010 Dec; 25(4):660.e9-16. PubMed ID: 20435433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.